Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IPG Photonics is a global leader in high-power fiber lasers and amplifiers, maintaining a significant presence in the healthcare sector through its IPG Medical division. The company specializes in the development of advanced thulium fiber lasers (TFL) and other fiber-based technologies for surgical, dental, and aesthetic applications. Their medical portfolio is particularly prominent in urology, where their systems are used for lithotripsy (kidney stone fragmentation) and the treatment of benign prostatic hyperplasia. By leveraging proprietary fiber laser technology, IPG provides medical professionals with tools that offer superior precision, faster procedure times, and improved patient outcomes compared to traditional Holmium lasers. The company is vertically integrated, manufacturing its own optical fibers and diode pumps to ensure high performance and reliability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IPG Photonics.